122 related articles for article (PubMed ID: 32796241)
1. 3P's of Wermer/MEN1 Syndrome on 68Ga-DOTANOC PET/CT Scan.
Tripathy S; Prakash S; Arun Raj ST; Kumar A; Shamim SA
Clin Nucl Med; 2020 Dec; 45(12):e516-e517. PubMed ID: 32796241
[TBL] [Abstract][Full Text] [Related]
2. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
Lastoria S; Marciello F; Faggiano A; Aloj L; Caracò C; Aurilio M; D'Ambrosio L; Di Gennaro F; Ramundo V; Camera L; De Luca L; Fonti R; Napolitano V; Colao A
Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-DOTANOC PET/CT in Multiple Endocrine Neoplasia 1 With Associated Adrenocortical Carcinoma.
Basheer S; Ratheesan R; Sarma M; Palaniswamy SS; Mathews A
Clin Nucl Med; 2022 May; 47(5):e389-e392. PubMed ID: 35195585
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
Liu Y; Zhao X; Zhang J; Wang J; Zhang Z; Dai M; Wang N; Jing F; Wang T; Tian W
Medicine (Baltimore); 2022 Aug; 101(34):e30252. PubMed ID: 36042606
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
Morgat C; Vélayoudom-Céphise FL; Schwartz P; Guyot M; Gaye D; Vimont D; Schulz J; Mazère J; Nunes ML; Smith D; Hindié E; Fernandez P; Tabarin A
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1258-66. PubMed ID: 26819103
[TBL] [Abstract][Full Text] [Related]
8. The Wandering Mesenteric Lymph Node: Delayed 68Ga-DOTANOC PET/CT Imaging to Overcome a Potential Pitfall.
Zanoni L; Zompatori M; Scalorbi F; Fanti S; Ambrosini V
Clin Nucl Med; 2017 May; 42(5):e253-e254. PubMed ID: 28263209
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
Jullien M; Reichert T; D'Anella P; Castinetti F; Barlier A; Brue T; Taieb D; Cuny T
Ann Endocrinol (Paris); 2020 Feb; 81(1):39-43. PubMed ID: 31982106
[TBL] [Abstract][Full Text] [Related]
10. 68Ga-DOTANOC somatostatin receptor PET-CT imaging in multiple myeloma.
Sharma P; Dhull VS; Suman S; Bal C; Malhotra A; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):374-5. PubMed ID: 23640227
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
12. Ectopic pituitary adenoma with empty sella in the setting of MEN-1 syndrome: detection with 68Ga-DOTANOC PET/CT.
Naswa N; Das CJ; Sharma P; Karunanithi S; Bal C; Kumar R
Jpn J Radiol; 2012 Nov; 30(9):783-6. PubMed ID: 22923184
[TBL] [Abstract][Full Text] [Related]
13. Relevant Discordance Between 68Ga-DOTATATE and 68Ga-DOTANOC in SDHB-Related Metastatic Paraganglioma: Is Affinity to Somatostatin Receptor 2 the Key?
Janssen I; Wolf KI; Chui CH; Millo CM; Pacak K
Clin Nucl Med; 2017 Mar; 42(3):211-213. PubMed ID: 28033222
[TBL] [Abstract][Full Text] [Related]
14. 68Ga-DOTANOC PET-CT demonstrating in vivo somatostatin receptor expression in idiopathic gynecomastia.
Dhull VS; Sharma P; Singla S; Singhal A; Bal C; Kumar R
Clin Nucl Med; 2013 Aug; 38(8):e324-5. PubMed ID: 23531768
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma.
Sharma P; Arora S; Karunanithi S; Khadgawat R; Durgapal P; Sharma R; Kandasamy D; Bal C; Kumar R
Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):69-76. PubMed ID: 24740163
[TBL] [Abstract][Full Text] [Related]
16. Metastatic neuroendocrine carcinoma presenting as a "Superscan" on 68Ga-DOTANOC somatostatin receptor PET/CT.
Naswa N; Karunanithi S; Soundararajan R; Das KJ; Agarwal KK; Malhotra A; Bal C; Kumar R
Clin Nucl Med; 2012 Sep; 37(9):892-4. PubMed ID: 22889781
[TBL] [Abstract][Full Text] [Related]
17. Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.
Sadowski SM; Millo C; Cottle-Delisle C; Merkel R; Yang LA; Herscovitch P; Pacak K; Simonds WF; Marx SJ; Kebebew E
J Am Coll Surg; 2015 Aug; 221(2):509-17. PubMed ID: 26206648
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic imaging in MEN1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
Kostiainen I; Majala S; Schildt J; Parviainen H; Kauhanen S; Seppänen H; Miettinen PJ; Matikainen N; Ryhänen EM; Schalin-Jäntti C
Eur J Endocrinol; 2023 May; 188(5):421-429. PubMed ID: 36943311
[TBL] [Abstract][Full Text] [Related]
19. Incremental value of
Xia Y; Wang Z; Zhao Y; Liu H; Chen Y
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):45-46. PubMed ID: 31551189
[No Abstract] [Full Text] [Related]
20. Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.
Albers MB; Librizzi D; Lopez CL; Manoharan J; Apitzsch JC; Slater EP; Bollmann C; Kann PH; Bartsch DK
World J Surg; 2017 Jun; 41(6):1521-1527. PubMed ID: 28138732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]